Update: Respiratory Syncytial Virus Activity - United States, 1997-98 Season

Morbidity and Mortality Weekly Report

Volumn 47, Issue 48, 1998, Pages 1043-1045

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; HUMAN; SEASON; UNITED STATES; VIRUS INFECTION;

HUMANS; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; SEASONS; UNITED STATES;

EID: 0032509297     PISSN: 01492195     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Institute of Medicine. [Appendix N]: Prospects for immunizing against respiratory syncytial virus. In: Institute of Medicine. New vaccine development: establishing priorities. Vol II. Disease importance in developing countries. Washington, DC: National Academy Press, 1986:299-307.
2. Gilchrist S, Török TJ, Gary HE Jr, Alexander JP, Anderson LJ. National surveillance for respiratory syncytial virus, United States, 1985-1990. J Infect Dis 1994; 170:986-90.
3. Dowell SF, Anderson LJ, Gary HE Jr, et al. Respiratory syncytial virus is an important cause of community-acquired lower respiratory infection among hospitalized adults. J Pediatr 1996;174:456-62.
4. Wang EEL, Law BJ, Stephens D, et al. Pediatric Investigators' Collaborative Network on Infections in Canada (PICNIC): prospective study of risk factors and outcomes in patients hospitalized with respiratory syncytial viral lower respiratory tract infections. J Pediatr 1995;126:212-9.
5. Whimbey E, Couch RB, Englund JA, et al. Respiratory syncytial virus pneumonia in hospitalized adult patients with leukemia. Clin Infect Dis 1995;21:376-9.
6. CDC. Guideline for infection control in health care personnel, 1998. Am J Infect Control 1998; 26:289-354.
7. Committee on Infectious Diseases, Committee on Fetus and Newborn, American Academy of Pediatrics. Prevention of respiratory syncytial virus infections: indications for the use of palivizumab and update on the use of RSV-IGIV. Pediatrics 1998;102:1211-6.
8. Committee on Infectious Diseases, American Academy of Pediatrics. Reassessment of the indications for ribavirin therapy in respiratory syncytial virus infections. Pediatrics 1996;97: 137-40.